Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Management of dabigatran-induced bleeding: expert statement.

Fries D, Giurea A, Gütl M, Halbmayer WM, Kozek-Langenecker S, Pachucki A, Roithinger F, Steinlechner B, Thaler H, Weltermann A.

Wien Klin Wochenschr. 2013 Nov;125(21-22):721-9. doi: 10.1007/s00508-013-0430-3. Epub 2013 Nov 12.

2.

[Dabigatran therapy--perioperative management and interpretation of coagulation tests].

Spannagl M, Bauersachs R, Debus ES, Gawaz M, Gerlach H, Haas S, Hach-Wunderle V, Lindhoff-Last E, Riess H, Schellong S, Schinzel H, Bode C.

Hamostaseologie. 2012;32(4):294-305. doi: 10.5482/ha-2012030004. German.

PMID:
23114798
3.

Dabigatran: life-threatening bleeding.

[No authors listed]

Prescrire Int. 2013 Feb;22(135):41-3. Review.

PMID:
23444501
4.

Dabigatran: patient management in specific clinical settings.

Kyrle PA, Binder K, Eichinger S, Függer R, Gollackner B, Hiesmayr JM, Huber K, Lang W, Perger P, Quehenberger P, Roithinger FX, Schmaldienst S, Weltermann A, Domanovits H.

Wien Klin Wochenschr. 2014 Sep;126(17-18):503-8. doi: 10.1007/s00508-014-0581-x. Epub 2014 Aug 20.

5.

Dabigatran, bleeding, and the regulators.

Moore TJ, Cohen MR, Mattison DR.

BMJ. 2014 Jul 23;349:g4517. doi: 10.1136/bmj.g4517. No abstract available.

PMID:
25056265
6.

Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.

Matute MC, Guillán M, García-Caldentey J, Buisan J, Aparicio M, Masjuan J, Alonso de Leciñana M.

Thromb Haemost. 2011 Jul;106(1):178-9. doi: 10.1160/TH11-01-0042. Epub 2011 Apr 20. No abstract available.

PMID:
21505718
7.

The trouble with dabigatran.

Charlton B, Redberg R.

BMJ. 2014 Jul 23;349:g4681. doi: 10.1136/bmj.g4681. No abstract available.

PMID:
25055830
8.

Dabigatran: how the drug company withheld important analyses.

Cohen D.

BMJ. 2014 Jul 23;349:g4670. doi: 10.1136/bmj.g4670. No abstract available.

9.

Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.

Weltermann A, Brodmann M, Domanovits H, Eber B, Gottsauner-Wolf M, Halbmayer WM, Hiesmayr JM, Kyrle PA, Längle F, Roithinger FX, Watzke H, Windhager R, Wolf C, Zweiker R.

Wien Klin Wochenschr. 2012 May;124(9-10):340-7. doi: 10.1007/s00508-012-0166-5. Epub 2012 May 11.

10.

The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.

Alikhan R, Rayment R, Keeling D, Baglin T, Benson G, Green L, Marshall S, Patel R, Pavord S, Rose P, Tait C.

Emerg Med J. 2014 Feb;31(2):163-8. doi: 10.1136/emermed-2012-201976. Epub 2013 Feb 22. Review.

11.

[Dabigatran and emergency operation on a peritonitis patient].

Ilmakunnas M, Louhimo J, Lassila R.

Duodecim. 2012;128(7):753-7. Review. Finnish.

PMID:
22612026
12.

Concerns over data in key dabigatran trial.

Cohen D.

BMJ. 2014 Jul 23;349:g4747. doi: 10.1136/bmj.g4747. No abstract available.

PMID:
25055831
13.

Dabigatran "non-inferior" to warfarin, but only just.

[No authors listed]

BMJ. 2013 Feb 27;346:f1219. doi: 10.1136/bmj.f1219. No abstract available.

PMID:
23447339
14.

Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.

Davis C, Robertson C, Shivakumar S, Lee M.

J Can Dent Assoc. 2013;79:d74. Review.

15.

Thrombosis on a mechanical mitral valve anticoagulated with dabigatran.

Coulter S, Campos K.

J Thromb Thrombolysis. 2014;37(2):84-6. doi: 10.1007/s11239-013-0935-7. No abstract available.

PMID:
23813022
16.

Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices.

Baumann Kreuziger LM, Reding MT.

Thromb Res. 2013 Aug;132(2):e161-3. doi: 10.1016/j.thromres.2013.07.011. Epub 2013 Jul 31. No abstract available.

17.

Is there really misuse and abuse of dabigatran?

Eikelboom JW, Hankey GJ.

Med J Aust. 2013 Apr 15;198(7):358-9. No abstract available.

PMID:
23581946
18.

[Re-allign (randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran ftexilate in patients after heart valve replacement)].

Zeus T, Nitschmann S, Kelm M.

Internist (Berl). 2014 Sep;55(9):1108-9, 1111. doi: 10.1007/s00108-014-3559-x. German. No abstract available.

PMID:
25070615
19.

Dabigatran for stroke prevention in atrial fibrillation.

Hohnloser SH, Diener HC.

Hamostaseologie. 2012;32(3):216-20. doi: 10.5482/ha-1196. Epub 2012 Jun 28.

PMID:
22739760
20.

Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran.

Getta B, Muller N, Motum P, Hsu D, Zebeljan D, Rosenfeld D.

Br J Haematol. 2015 May;169(4):603-4. doi: 10.1111/bjh.13236. Epub 2014 Nov 25. No abstract available.

PMID:
25425051

Supplemental Content

Support Center